Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: BRAVEHEART who wrote (548)	2/24/2000 10:39:00 AM
From: tuck	Respond to of 586

Jeffrey, It's partly a matter of post expiration portfolio rebablancing. Anyhow, Ameritrade executed my 4 1/2 limit well, getting me out at 5 11/64. When my chart reading gets better than my instincts, I'll rely on it more. CYPB is showing more promise with this news. I thought I read 30% as the response rate for PROSORBA for RA. Maybe that was for complete remission. I expect CYPB to consolidate now Jeffrey; I might get back in later if it does dip. Almost got a double in about a week. Thanks again for the heads up here. Cheers, Tuck